CDK1 and melanoma: Likewise, Icariside II increased the percentage of A375 human melanoma cells at the G0/G1 boundary with downregulations of cyclin E, cyclin B1, CDK2, and phosphorylated-CDK1 (p-CDK1) (Wu et al., 2015).